Nkarta to Participate in an April Investor Conference

Rhea-AI Summary

Nkarta (Nasdaq: NKTX), a biopharmaceutical company specializing in engineered natural killer (NK) cell therapies, has announced its upcoming participation in the 24th Annual Needham Virtual Healthcare Conference.

The company will engage in a fireside chat scheduled for April 8, 2025, at 11:00 a.m. ET. Investors and interested parties can access a live webcast of the event through the Investors section of Nkarta's website. The presentation recording will remain available on www.nkartatx.com for approximately 90 days following the event.

News Market Reaction

+0.27%

1 alert

+0.27% News Effect

On the day this news was published, NKTX gained 0.27%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SOUTH SAN FRANCISCO, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference:

24th Annual Needham Virtual Healthcare Conference

April 8, 2025

11:00 a.m. ET – fireside chat

A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately 90 days.

About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for autoimmune diseases. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep therapeutic activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com.

Nkarta Media/Investor Contact:
Nadir Mahmood
Nkarta, Inc.
nmahmood@nkartatx.com

FAQ

When is Nkarta (NKTX) presenting at the Needham Healthcare Conference 2025?

Nkarta will present at the 24th Annual Needham Virtual Healthcare Conference on April 8, 2025, at 11:00 a.m. ET in a fireside chat format.

How can investors watch Nkarta's (NKTX) Needham Conference presentation?

Investors can watch the presentation via live webcast on Nkarta's website (www.nkartatx.com) in the Investors section.

How long will Nkarta's (NKTX) Needham Conference presentation be available for replay?

The presentation replay will be archived on Nkarta's website for approximately 90 days.

What type of therapies does Nkarta (NKTX) develop?

Nkarta develops engineered natural killer (NK) cell therapies.